Evidence map›Paper›PMID 29627591›Full record

ArticleNeuroImage2019

Organization of area hV5/MT+ in subjects with homonymous visual field defects.

Amalia Papanikolaou, Georgios A Keliris, T Dorina Papageorgiou, Ulrich Schiefer, Nikos K Logothetis, Stelios M Smirnakis

Abstract read
In one paragraph

Article in NeuroImage, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Cortical response to transient and long-term visual field loss.Cerebral cortex (New York, N.Y. : 1991) · 2025
    Article
  2. Review
  3. Individualized functional magnetic resonance imaging neuromodulation enhances visuospatial perception: a proof-of-concept study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amalia PapanikolaouInstitute of Behavioural Neuroscience, Department of Experimental Psychology, University College London, London WC1H 0AP, UK; Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany. Electronic address: amalia.papanikolaou@ucl.ac.uk.
Georgios A KelirisMax Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany; Bio-Imaging Lab, University of Antwerp, 2610 Wilrijk, Belgium; Bernstein Center for Computational Neuroscience, 72076 Tuebingen, Germany.
T Dorina PapageorgiouDepartment of Neurology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX 77030, USA; Department of Electrical & Computer Engineering, George R. Brown School of Engineering, Rice University, TX 77005 USA.
Ulrich SchieferCenter for Ophthalmology, University of Tuebingen, 72076 Tuebingen, Germany; Competence Center Vision Research, Study Course "Ophthalmic Optics", Faculty of Optics & Mechatronics, University of Applied Sciences, Aalen, Germany.
Nikos K LogothetisMax Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany; Division of Imaging Science and Biomedical Engineering, University of Manchester, Manchester M13 9PT, UK.
Stelios M SmirnakisDepartment of Neurology, Brigham and Women's Hospital and Jamaica Plain VA Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: smsmirnakis@bwh.harvard.edu.

Funding

VISUAL SCIENCEST32EY007001 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$3.7M
Population receptive field analysis in subjects with area V1+ lesions.R01EY024019 · NEI · BRIGHAM AND WOMEN'S HOSPITAL · PI SMIRNAKIS, STELIOS MANOLIS · 2014 to 2017
$1.6M
Mentored Research Training in Rehabilitation ScienceT32HD049350 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEVIN, HARVEY · 2006 to 2010
$991k
NEI NIH HHS R01 EY024019NEI NIH HHS T32 EY007001NICHD NIH HHS T32 HD049350
6 · The paper itself

Abstract

Damage to the primary visual cortex (V1) leads to a visual field loss (scotoma) in the retinotopically corresponding part of the visual field. Nonetheless, a small amount of residual visual sensitivity persists within the blind field. This residual capacity has been linked to activity observed in the middle temporal area complex (V5/MT+). However, it remains unknown whether the organization of hV5/MT+ changes following early visual cortical lesions. We studied the organization of area hV5/MT+ of five patients with dense homonymous defects in a quadrant of the visual field as a result of partial V1+ or optic radiation lesions. To do so, we developed a new method, which models the boundaries of population receptive fields directly from the BOLD signal of each voxel in the visual cortex. We found responses in hV5/MT+ arising inside the scotoma for all patients and identified two possible sources of activation: 1) responses might originate from partially lesioned parts of area V1 corresponding to the scotoma, and 2) responses can also originate independent of area V1 input suggesting the existence of functional V1-bypassing pathways. Apparently, visually driven activity observed in hV5/MT+ is not sufficient to mediate conscious vision. More surprisingly, visually driven activity in corresponding regions of V1 and early extrastriate areas including hV5/MT+ did not guarantee visual perception in the group of patients with post-geniculate lesions that we examined. This suggests that the fine coordination of visual activity patterns across visual areas may be an important determinant of whether visual perception persists following visual cortical lesions.

Indexed as

ScotomaVision DisordersVisual CortexVisual PathwaysAdultEcho-Planar ImagingFemaleFunctional NeuroimagingHumansMaleMiddle AgedStrokeVisual FieldsVisual PerceptionBlindsightCortical lesionfMRIReorganizationVisual cortex

Identifiers

PMID29627591
PMCPMC7485907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.